BR112014000329A2 - método de análise de distúrbios cardiovasculares e uso do mesmo - Google Patents
método de análise de distúrbios cardiovasculares e uso do mesmoInfo
- Publication number
- BR112014000329A2 BR112014000329A2 BR112014000329A BR112014000329A BR112014000329A2 BR 112014000329 A2 BR112014000329 A2 BR 112014000329A2 BR 112014000329 A BR112014000329 A BR 112014000329A BR 112014000329 A BR112014000329 A BR 112014000329A BR 112014000329 A2 BR112014000329 A2 BR 112014000329A2
- Authority
- BR
- Brazil
- Prior art keywords
- analysis
- cardiovascular disorders
- cardiovascular
- disorders
- Prior art date
Links
- 208000024172 Cardiovascular disease Diseases 0.000 title 1
- 238000004458 analytical method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5026—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell morphology
-
- G01N15/1433—
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5064—Endothelial cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161505481P | 2011-07-07 | 2011-07-07 | |
| PCT/US2012/045832 WO2013006828A1 (en) | 2011-07-07 | 2012-07-06 | Method of analyzing cardiovascular disorders and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112014000329A2 true BR112014000329A2 (pt) | 2017-02-07 |
Family
ID=46690685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014000329A BR112014000329A2 (pt) | 2011-07-07 | 2012-07-06 | método de análise de distúrbios cardiovasculares e uso do mesmo |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20130157347A1 (pt) |
| EP (1) | EP2729802B1 (pt) |
| JP (1) | JP2014523533A (pt) |
| CN (1) | CN103782170A (pt) |
| BR (1) | BR112014000329A2 (pt) |
| CA (1) | CA2840226A1 (pt) |
| MX (1) | MX2014000095A (pt) |
| WO (1) | WO2013006828A1 (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9349176B2 (en) * | 2009-07-15 | 2016-05-24 | Mayo Foundation For Medical Education And Research | Computer-aided detection (CAD) of intracranial aneurysms |
| CN115060882A (zh) | 2009-10-21 | 2022-09-16 | 斯克里普斯研究所 | 用非稀有细胞检测稀有细胞的方法 |
| CN107315086B (zh) | 2011-06-29 | 2019-09-10 | 中央研究院 | 使用表面涂层对生物物质的捕获、纯化和释放 |
| EA201690995A1 (ru) * | 2013-12-09 | 2016-11-30 | Зе Скриппс Рисёрч Инститьют | Способы обнаружения и количественного анализа циркулирующих эндотелиальных клеток |
| US10527624B2 (en) | 2014-01-27 | 2020-01-07 | Epic Sciences, Inc. | Circulating tumor cell diagnostics for prostate cancer biomarkers |
| US10545151B2 (en) | 2014-02-21 | 2020-01-28 | Epic Sciences, Inc. | Methods for analyzing rare circulating cells |
| EP3126814B1 (en) | 2014-04-01 | 2019-06-12 | Academia Sinica | Methods and systems for cancer diagnosis and prognosis |
| CN107155344A (zh) | 2014-07-23 | 2017-09-12 | 澳大利亚国立大学 | 平面传感器阵列 |
| EP2998026B1 (en) | 2014-08-26 | 2024-01-17 | Academia Sinica | Collector architecture layout design |
| JP6673224B2 (ja) * | 2014-12-25 | 2020-03-25 | コニカミノルタ株式会社 | 細胞画像解析方法及び細胞画像解析装置 |
| US10107726B2 (en) | 2016-03-16 | 2018-10-23 | Cellmax, Ltd. | Collection of suspended cells using a transferable membrane |
| CN109781975B (zh) * | 2017-11-14 | 2022-05-06 | 河南乾坤科技有限公司 | 富集循环稀有细胞的试剂及方法 |
| CN109545370B (zh) * | 2018-10-27 | 2023-08-22 | 平安医疗健康管理股份有限公司 | 基于样本处理的病种确定方法、装置及终端 |
| CN112529843A (zh) * | 2020-11-23 | 2021-03-19 | 集美大学 | 一种用于识别异常上皮细胞的方法和系统 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7785810B2 (en) * | 2000-09-09 | 2010-08-31 | The Research Foundation Of State University Of New York | Method and compositions for isolating metastatic cancer cells, and use in measuring metastatic potential of a cancer thereof |
| CA2431818C (en) * | 2001-01-05 | 2011-11-22 | Immunivest Corporation | Devices and methods to image objects |
| EP1501917A4 (en) * | 2002-05-03 | 2006-04-19 | Immunivest Corp | DEVICE AND METHOD FOR ANALYTICAL CELL IMAGING |
| AU2004286307A1 (en) * | 2003-10-31 | 2005-05-12 | Vitatex, Inc. | Blood test prototypes and methods for the detection of circulating tumor and endothelial cells |
| WO2006020936A2 (en) * | 2004-08-12 | 2006-02-23 | Immunivest Corporation | A method for assessing disease states by profile analysis of isolated circulating endothelial cells |
| CN101305087A (zh) * | 2005-09-15 | 2008-11-12 | 阿尔特弥斯康复公司 | 用于磁富集细胞和其他颗粒的装置和方法 |
| CN1746901A (zh) * | 2005-09-19 | 2006-03-15 | 南京大学 | 肺癌早期细胞涂片彩色图像信息的计算机智能化处理的方法及其处理设备 |
| EP2059801A4 (en) * | 2006-09-05 | 2013-10-09 | Veridex Llc | METHOD FOR CLASSIFYING CELLULAR PICTURES |
| US20090111826A1 (en) * | 2007-02-13 | 2009-04-30 | Louis Lange | Use of ranolazine for the treatment of cardiovascular diseases |
| CN101587043B (zh) * | 2008-05-20 | 2013-10-02 | 北京莱尔生物医药科技有限公司 | 从生物体液样本中富集与检测稀有细胞的整合方法 |
| WO2009143478A2 (en) * | 2008-05-22 | 2009-11-26 | Larry Mark Weisenthal | Efficient wellbeing assessment and improved treatment protocol |
| CN101339185B (zh) * | 2008-06-23 | 2011-03-02 | 武汉呵尔医疗科技发展有限公司 | 用于脱落细胞检测的自动显微成像仪及检测方法 |
| EP2306814B1 (en) * | 2008-07-24 | 2013-11-27 | Geno LLC | Methods for diagnosing and treating a heart condition in a patient |
| KR20120026551A (ko) * | 2009-05-15 | 2012-03-19 | 에스알유 바이오시스템즈, 인코포레이티드 | 세포 집단 및 혼합된 세포 집단에서의 변화의 검출 방법 |
| JP5746154B2 (ja) * | 2009-05-28 | 2015-07-08 | ザ クリーブランド クリニック ファウンデーションＴｈｅ Ｃｌｅｖｅｌａｎｄ ＣｌｉｎｉｃＦｏｕｎｄａｔｉｏｎ | 疾患の診断および予測のためのトリメチルアミン含有化合物 |
| CN115060882A (zh) * | 2009-10-21 | 2022-09-16 | 斯克里普斯研究所 | 用非稀有细胞检测稀有细胞的方法 |
| CN102812359A (zh) * | 2009-11-13 | 2012-12-05 | Bg医药公司 | 心肌梗死的风险因子和预测 |
-
2012
- 2012-07-06 US US13/543,661 patent/US20130157347A1/en not_active Abandoned
- 2012-07-06 BR BR112014000329A patent/BR112014000329A2/pt not_active IP Right Cessation
- 2012-07-06 CA CA2840226A patent/CA2840226A1/en not_active Abandoned
- 2012-07-06 MX MX2014000095A patent/MX2014000095A/es not_active Application Discontinuation
- 2012-07-06 EP EP20120748286 patent/EP2729802B1/en not_active Not-in-force
- 2012-07-06 WO PCT/US2012/045832 patent/WO2013006828A1/en active Application Filing
- 2012-07-06 JP JP2014519085A patent/JP2014523533A/ja active Pending
- 2012-07-06 CN CN201280043661.1A patent/CN103782170A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013006828A1 (en) | 2013-01-10 |
| JP2014523533A (ja) | 2014-09-11 |
| CA2840226A1 (en) | 2013-01-10 |
| US20130157347A1 (en) | 2013-06-20 |
| EP2729802A1 (en) | 2014-05-14 |
| MX2014000095A (es) | 2014-05-28 |
| CN103782170A (zh) | 2014-05-07 |
| EP2729802B1 (en) | 2015-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014000329A2 (pt) | método de análise de distúrbios cardiovasculares e uso do mesmo | |
| BR112014027450A2 (pt) | aparelho e métodos de análise microbiológica | |
| BR112014028366A2 (pt) | anticorpos anti-ly6e e imunoconjugados e métodos de uso | |
| CO7020870A2 (es) | Anticuerpos anti-htra1 y métodos de uso | |
| BR112014018136A2 (pt) | anticorpos ou uso e método para determinar | |
| DK2776833T3 (da) | Cobinder-understøttet testfremgangsmåde | |
| EP2670866A4 (en) | BIOMARKERS AND METHODS OF USE | |
| BR112014010175A2 (pt) | unidades de filtro, componentes e recursos destas e métodos de uso e construção | |
| BR112014002716A2 (pt) | anticorpos anti-poliubiquitina e métodos de uso | |
| BR112014012590A2 (pt) | anticorpos anti-cd98 e métodos de uso dos mesmos | |
| CO6801741A2 (es) | Derivados c4-monometil triterpenoides y sus métodos de uso | |
| BR112014009070A2 (pt) | método de síntese e intermediários úteis na preparação de pirrolobenzo-diazepinas | |
| CO6811822A2 (es) | Análisis de riesgos de infraestructura energética y remediación | |
| BR112013025355A2 (pt) | combinações de compostos de inibidor de akt e abiraterona e métodos de uso | |
| BR112013021373A2 (pt) | aparelho e método de bebida preparada | |
| BR112013007506A2 (pt) | piridinonas/pirazinonas - métodos de criação e de uso | |
| BR112013014119A2 (pt) | novos moduladores e métodos de uso | |
| CL2015001266A1 (es) | Anticuerpos de antihemaglutinina y métodos de uso. | |
| CO7000747A2 (es) | Anticuerpos anti-lrp5 y métodos de uso | |
| CO6862148A2 (es) | Composiciones transdérmicas de ibuprofeno y métodos de uso de las mismas | |
| DK3141548T3 (da) | Fremgangsmåder og mellemprodukter til fremstilling af azaindoler | |
| CO6940375A2 (es) | Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo | |
| BR112014010450A2 (pt) | composição e método | |
| BR112013013756A2 (pt) | conjunto de fixação pedicular multiaxial e método de uso | |
| CO6980641A2 (es) | Dispositivo de prueba para alergía y método de prueba para alergías |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |